Pfizer Inc. rates highest in shareholder yield but failed in that aspect according to Validea.

From Nasdaq: 2024-12-24 09:00:00

Validea’s guru fundamental report for Pfizer Inc (PFE) shows it rates highest using the Shareholder Yield Investor model by Meb Faber. This strategy looks for companies returning cash to shareholders via dividends, buybacks, and debt paydown. PFE is a large-cap growth stock in the Biotechnology & Drugs industry with a rating of 85% based on fundamentals and valuation. It passed tests in net payout yield, quality and debt, valuation, relative strength, but failed in shareholder yield. Meb Faber is the founder of Cambria Investments and his shareholder yield strategy focuses on creating value for shareholders. Validea is an investment research service that follows the strategies of investment legends.



Read more at Nasdaq: PFE Quantitative Stock Analysis | Nasdaq